神经修復和再生市场：依产品、手术和地区，2024年至2031年

神经修復与再生市场评估-2024-2031

神经损伤、神经系统疾病以及糖尿病等慢性疾病的发生率不断上升，对有效的神经再生疗法的需求也随之增加。政府资助再生医学研究和开发的举措以及微创手术的广泛使用促进了市场的扩张。此外，对个人化医疗和更特异性药物开发的日益重视为该行业带来了新的前景，预计到2024年将达到 88.4亿美元，到2031年将达到 158.8亿美元。

生物材料、干细胞疗法和 3D 列印等医疗技术的进步提高神经修復治疗的成功率。此外，人口老化以及对早期介入益处的认识不断提高也在推动市场成长，估计2024年至2031年期间的年复合成长率约为 8.37%。

神经修復与再生市场定义/概述

神经修復和再生是修復受损或受伤的神经组织并再次发挥功能的过程。神经移植、基于生物材料的支架、干细胞疗法和神经刺激用于促进癒合和再生。它用于治疗週边神经损伤、脊髓损伤、神经退化性疾病、糖尿病神经病变等。随着基因编辑、生物电子医学和个人化再生技术等先进治疗方法的不断研究，神经修復和再生的未来充满希望。持续的技术进步和对神经生物学的深入了解可能会带来突破，带来更有效、更快捷的治疗方案。

对个人化医疗的日益关注是否会推动神经修復和再生市场的发展？

随着对个人化医疗的日益重视，神经修復和再生产业预计将大幅成长。个人化医疗根据个人的基因特征、疾病特征和其他生物标记制定治疗方案，对神经系统疾病等复杂疾病特别有效。个人化的神经修復技术，包括基因治疗、干细胞治疗和改良的生物材料，实现更有效、更个人化的治疗。

2023年10月，美国国立卫生研究院（NIH）宣布未来五年增加2亿美元资金，以刺激个人化神经再生技术的创意研究。此外，FDA 继续批准针对神经系统疾病的个人化药物，允许新药更快上市。根据 Statista 的资料，全球个人化医疗市场预计在2023年价值达到 5,000亿美元，并在2024年至2030年期间以 11.5%的年复合成长率成长。对个人化医疗的重视不仅改善了治疗方法，而且还有助于扩大整个神经修復和再生产业，为患者提供更精确、更有效率、更有效的解决方案。

神经组织再生的併发症日益增多是否会阻碍神经修復和再生市场的成长？

神经组织再生的复杂性是神经修復再生领域拓展的一大障碍。神经组织，特别是中枢神经系统的神经组织很难癒合，因为成熟的神经细胞的再生能力有限。疤痕组织的形成、免疫系统反应和神经网路的复杂性都使成功治疗变得困难。此外，儘管生物材料、干细胞治疗和基因编辑方面的进步显示出巨大的前景，但将这些技术转化为复杂损伤的实用、安全和成功的治疗方法仍然是一个重大挑战。这种复杂性意味着更长的开发时间、增加的研究成本和监管障碍，减缓整个产业的成长。

然而，神经组织再生的复杂性虽然带来了障碍，但也刺激了该行业的创新。随着研究的进步，人们研究 3D 列印支架、基因疗法和客製化治疗等新方法来解决这些障碍。此外，神经系统疾病发生率的上升，加上再生医学资金的增加，为未来的突破创造了巨大的动力。虽然这些挑战可能会在短期内减缓市场成长，但它们也提供了独特的解决方案的潜力，并且从长远来看，随着新的、更有效的治疗方法的出现，可能会加速市场的演变。

目录

第1章 全球神经修復与再生市场简介

• 市场概况
• 研究范围
• 先决条件

第2章 执行摘要

第3章 经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第4章 神经修復与再生的全球市场展望

• 概述
• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 波特五力模型
• 价值链分析

第5章 全球神经修復和再生市场：依产品

• 概述
• 神经刺激与神经调节装置
• 生物材料

第6章 全球神经修復与再生市场：依手术

• 概述
• 神经移植
• 干细胞疗法

第7章 全球神经修復与再生市场：依地区

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第8章 全球神经修復与再生市场的竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第9章 公司简介

• Medtronic's Plc
• Axogen Corporation
• Baxter International Inc.
• Polygamic
• Integra LiveScience
• Cyberonics Inc.
• Stryker Corporation
• St. Judge Medical Inc.
• Boston Scientific Corporation
• Emerson Electric Company

第10章 重大进展

• 产品发布/开发
• 合併和收购
• 业务扩展
• 伙伴关係和合作关係

第11章 附录

• 相关研究

Nerve Repair and Regeneration Market Valuation - 2024-2031

The rising prevalence of nerve injuries, neurological illnesses, and chronic diseases like diabetes is increasing the need for effective nerve regeneration treatments. Government measures to fund regenerative medicine research and development, as well as increased use of less invasive procedures, are all contributing to market expansion. Furthermore, the increased emphasis on customized medicine and the development of more specific medicines are creating new prospects in the field is fueling the USD 8.84 Billion in 2024 and reaching USD 15.88 Billion by 2031.

Advances in medical technology, such as biomaterials, stem cell therapies, and 3D printing, are improving the success of nerve repair treatments. Furthermore, increasing awareness of the benefits of early intervention, along with an aging population, is driving market growth is grow at a CAGR of about 8.37% from 2024 to 2031.

Nerve Repair and Regeneration Market: Definition/ Overview

Nerve repair and regeneration is the process of repairing damaged or injured nerve tissues so that they can function again. It uses nerve grafts, biomaterial-based scaffolds, stem cell therapy, and neurostimulation to promote healing and regeneration. Applications include the therapy of peripheral nerve injuries, spinal cord injuries, neurodegenerative disorders, and diabetic neuropathy. The future of nerve repair and regeneration looks hopeful, with continuous research into advanced therapeutics including gene editing, bioelectronic medicine, and individualized regenerative techniques. Continued technology advancements and a better understanding of neuron biology are expected to drive breakthroughs, providing promise for more effective and faster healing options.

Will Rising Focused on Personalized Medicine Propel the Nerve Repair And Regeneration Market?

The increasing emphasis on personalized therapy is expected to greatly boost the nerve repair and regeneration industry. Personalized medicine tailors therapies to individuals' genetic profiles, disease characteristics, and other biomarkers, which is especially useful for complicated ailments such as neurological disorders. Personalized techniques to nerve repair, such as gene therapies, stem cell treatments, and biomaterial modification, are enabling more effective and tailored therapies.

In October 2023, the National Institutes of Health (NIH) announced a USD 200 Million funding increase over the following five years to stimulate creative research into individualized nerve regeneration techniques. Furthermore, the FDA continues to approve tailored medicines for neurological diseases, which allows novel medications to enter the market more quickly. According to Statista, the global market for personalized medicine was valued at USD 500 Billion in 2023 and is expected to increase at an 11.5% CAGR between 2024 and 2030. As a result, the growing emphasis on customized medicine is not only improving therapeutic alternatives, but also driving the overall expansion of the nerve repair and regeneration industry, providing more accurate, efficient, and effective solutions to patients.

Will Rising Complexity of Nerve Tissue Regeneration Hinder the Growth of the Nerve Repair and Regeneration Market?

The increasing complexity of nerve tissue regeneration poses a significant obstacle to the expansion of the nerve repair and regeneration sector. Nerve tissue, particularly in the central nervous system, is naturally difficult to heal because mature neurons have limited regenerative ability. Scar tissue formation, immune system responses, and the complexity of neural networks all make successful treatment difficult. Furthermore, while advances in biomaterials, stem cell therapy, and gene editing show great promise, turning these technologies into practical, safe, and successful treatments for complicated injuries remains a significant challenge. This complexity results in longer development timeframes, greater research costs, and regulatory barriers, reducing total industry growth.

However, while the complexity of nerve tissue regeneration creates obstacles, it also stimulates industry innovation. As research progresses, novel approaches such as 3D-printed scaffolds, gene therapies, and tailored treatments are being investigated to address these obstacles. Furthermore, the rising prevalence of neurological illnesses, combined with greater funding in regenerative medicine, creates a significant incentive for future breakthroughs. While the difficulties may slow immediate market growth, they also provide potential for unique solutions, which, in the long run, may accelerate the market's evolution as new, more effective treatments become available.

Category-Wise Acumens

Will Rising Demand of Biomaterials Propel the Nerve Repair And Regeneration Market?

The biomaterials segment is expected to hold major share in the nerve repair and regeneration market, since these materials are essential for facilitating the mending of damaged nerves. Biomaterials, such as nerve conduits, scaffolds, and grafts, can help bridge nerve gaps and promote tissue regeneration, particularly in situations of peripheral nerve injury. Biomaterials have received widespread popularity as a result of advances in material science, such as the development of biocompatible, biodegradable, and synthetic choices, and their proven efficiency in nerve repair. Leading firms such as AxoGen, Inc. and Integra LifeSciences are developing biomaterial-based solutions, with AxoGen's Avance Nerve Graft being a notable example. According to a Verified Market Research the biomaterials market is predicted to exhibit a CAGR of 14.80%, driven by growing clinical uses and technological advances in nerve regeneration products.

In April 2023, The US Food and Drug Administration (FDA) approved novel biomaterial-based nerve healing devices, speeding up the clearance process and encouraging additional companies to innovate in this area. Furthermore, the European Union's Horizon 2020 initiative has provided significant financing for research into regenerative medicine and advanced biomaterials, accelerating market growth. With an increasing prevalence of nerve injuries and neurological illnesses, as well as greater investment in research and product development, demand for biomaterials is predicted to rise further, stimulating additional growth in the nerve repair and regeneration market.

However, the neurostimulation and neuromodulation devices market is the fastest expanding, driven by rising demand for non-invasive therapies for neurological illnesses and chronic pain. Technologies such as transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS) are gaining appeal as alternatives to standard surgical therapies, propelling the category forward. Neurostimulation devices are expected to rise rapidly in the next years as a result of ongoing technology innovations and increased patient awareness.

Will Rising Innovation of Nerve Grafting Fuel the Nerve Repair And Regeneration Market?

The increasing innovation in nerve grafting is expected to greatly boost the growth of the nerve repair and regeneration market, as well as upsurge its dominance over the forecast period. Nerve grafting, which uses autografts, allografts, or synthetic materials to bridge nerve gaps, has long been a staple of peripheral nerve healing. However, recent advances in nerve grafting procedures, such as the invention of bioengineered and biodegradable grafts, have resulted in better results for patients with complex nerve injuries.

In June 2023, the National Institutes of Health (NIH) announced a USD 30 Million grant to research initiatives aimed at increasing neuron regeneration through new grafting techniques such as tissue-engineered scaffolds. In March 2023, the European Commission's Horizon Europe initiative, which began, has committed funds to assist advanced biomaterial research for nerve rehabilitation, including the creation of next-generation grafts. These advancements, combined with a growing knowledge of nerve grafting's importance in treating nerve injuries, are projected to drive market growth. As new technology and techniques improve, nerve grafting will undoubtedly become more popular, making it a crucial driver of growth in the nerve repair and regeneration industry.

However, stem cell therapy is the fastest-growing component of this science. Stem cell-based treatments have the potential to significantly improve nerve regeneration by boosting tissue repair, increasing growth hormones, and minimizing scar formation. With developments in regenerative medicine and ongoing clinical trials, stem cell therapy is gaining popularity as a novel alternative to standard treatments. The expanding emphasis on regeneration techniques, combined with promising results from recent studies, is driving the rapid growth of this market, with an increasing number of hospitals and research institutions implementing stem cell therapies in nerve repair.

Country/Region-wise

Will Rising Advanced Healthcare Infrastructure in North America Drive the Nerve Repair And Regeneration Market?

The growing advanced healthcare infrastructure in North America is projected to play a significant role in driving the region's leadership in the nerve repair and regeneration market. The region has cutting-edge healthcare facilities, dynamic research and development ecosystems, and a high level of investment in medical technologies, all of which contribute to the quick acceptance of advanced nerve regeneration therapies. Companies such as Medtronic, AxoGen, and Integra LifeSciences are exploiting North America's infrastructure to launch novel nerve repair devices and therapies. Furthermore, the rising prevalence of neurological diseases, combined with a strong demand for less invasive therapies, has propelled the market's growth.

In September 2023, The United States government would contribute $50 million to advance nerve healing technology research through the National Institutes of Health (NIH). Furthermore, the FDA has accelerated the approval of numerous nerve repair treatments, including AxoGen's Avance Nerve Graft, which has become widely used in clinical settings. These efforts not only speed up the availability of novel treatments, but they also ensure that healthcare providers have access to cutting-edge technology. With rising patient demand and a favorable legislative and financial climate, North America's modern healthcare infrastructure is expected to propel significant growth in the nerve repair and regeneration market, paving the way for future innovation and accessibility.

Will Growing Awareness of Nerve Regeneration Treatments in Asia Pacific Propel the Nerve Repair and Regeneration Market?

The increasing awareness of nerve regeneration treatments in the Asia-Pacific region is projected to drive the nerve repair and regeneration market. With a rapidly developing healthcare industry, improved access to advanced medical treatments, and a growing emphasis on neurological health, there is a greater need for novel nerve repair options. As the frequency of nerve injuries, neurological illnesses such as Parkinson's disease, and diabetes-related neuropathy rises in China, India, and Japan, healthcare practitioners and patients are becoming more aware of the benefits of nerve regeneration therapy.

In September 2023, the Indian Ministry of Health and Family Welfare announced the launch of new healthcare programs aiming at boosting access to cutting-edge treatments such as nerve repair technologies. Similarly, China has made considerable investments in regenerative medicine research through its 14th Five-Year Plan (2021-2025), which includes funding for sophisticated healthcare technology such as stem cell therapies and bioengineering solutions. These government efforts, together with the growing use of minimally invasive surgical procedures and more patient awareness, are helping to drive market growth.

Competitive Landscape

The nerve repair and regeneration market is characterized by a competitive landscape driven by advancements in biomaterials, stem cell therapies, and nerve conduit technologies. Companies are increasingly focusing on developing novel solutions for peripheral nerve injuries, spinal cord regeneration, and neurological disorders. Key strategies include strategic partnerships, acquisitions, and the development of products with enhanced efficacy and minimal side effects. Additionally, emerging technologies like 3D printing, gene therapy, and neurostimulation are opening new avenues for treatment. The market is also shaped by increasing healthcare awareness, aging populations, and growing demand for minimally invasive procedures.

Some of the prominent players operating in the nerve repair and regeneration market include:

Medtronics plc

Axogen Corporation

Baxter International, Inc.

Polyganics

Integra LifeSciences

Cyberonics, Inc.

Stryker Corporation

Jude Medical, Inc.

Boston Scientific Corporation.

Latest Developments

In May 2023, Stryker Corporation acquired Wright Medical Group to extend its range of regenerative medicine and nerve repair products. The acquisition expands Stryker's expertise in tissue healing and bioengineering, establishing the business as a stronger participant in the nerve regeneration market, particularly in severe nerve injuries.

In August 2023, Integra LifeSciences revealed their innovative NeuraGen(R) 3D Nerve Conduit, which is intended to create an ideal environment for nerve regeneration. This breakthrough employs a revolutionary 3D matrix technology that promotes cell development and long-term healing, particularly in bigger nerve gaps. Integra's growth is projected to solidify its position in the peripheral nerve repair industry.

Nerve Repair and Regeneration Market, By Category

• Product:
• Neurostimulation and Neuromodulation Devices
• Biomaterial
• Surgery:
• Nerve Grafting
• Stem Cell Therapy
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NERVE REPAIR AND REGENERATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NERVE REPAIR AND REGENERATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Neurostimulation and Neuromodulation Devices
• 5.3 Biomaterial

6 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY

• 6.1 Overview
• 6.2 Nerve Grafting
• 6.3 Stem Cell Therapy

7 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NERVE REPAIR AND REGENERATION MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Medtronic's Plc
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Axogen Corporation
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Baxter International Inc.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Polygamic
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Integra LiveScience
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Cyberonics Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Stryker Corporation
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 St. Judge Medical Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Boston Scientific Corporation
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Emerson Electric Company
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research